Korea's new Covid-19 cases spiked to over 71,000 on Tuesday amid concerns that daily infections could sharply rise again ahead of the winter months.The country reported 71,476 new COVID-19 infections, including 84 cases from overseas, bringing the total caseload to 27,031,319, according to data from
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – Lunit is well-known among the Radiological Society of North America (RSNA) community for its top-notch artificial intelligence (AI) technology in the field of medical imaging.The company was one of the first Korean AI medical imaging c
What measures prevent the departure of exhausted medical personnel due to the prolonged Covid-19 pandemic? Is there a way to make patients who left the hospital due to Covid-19 visit the hospital again?In answer to these questions, “trust” was cited as a virtue that hospitals in the post-Covid-19 er
Health officials from ASEAN countries gathered to discuss enhancing healthcare systems with a special focus on developing universal healthcare coverage (UHC) and health security with the help of Korea’s expertise at a meeting in Seoul on Tuesday.The Association of Southeast Asian Nations (ASEAN) pro
Medical professionals and other healthcare experts agree on the need for Korea to introduce telemedicine but disagree on “how.”A recent survey by the National Evidence-based healthcare Collaborating Agency (NECA) confirmed it, with respondents agreeing on some issues but showing differences in other
VUNO, a Seoul-based medical AI solution company, said Tuesday that it won approval for VUNO Med-Fundus AI, an AI-based fundus reading device, from Taiwan’s Food and Drug Administration(TFDA).The company said VUNO Med-Fundus AI, designed for diagnosis of retinal diseases based on fundus images, was t
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent -- Medical IP said it introduced new technologies to help advance the radiology industry during the Radiological Society of North America (RSNA) 2022, being held in Chicago, Ill., the U.S. until Thursday this week. The company's technolo
Handok will likely suffer a significant drop in turnover next year, as AstraZeneca decided to retrieve the sales rights of some rare drugs Handok introduced and marketed in Korea, according to industry sources on Tuesday.The estimated sales drop will amount to 50 billion won ($37.3 million), account
CTC Bio said on Tuesday that it has signed a memorandum of understanding (MOU) with Co-Evolution Network LLC (CoNet LLC), a Japanese company, to develop cannabidiol (CBD) oral dissolving films (ODF).CBD refers to a substance that is utilized and distributed by excluding hallucinogenic drugs and is u
Despite Korea's new Covid-19 cases falling below 25,000 approximately half of the previous day (47,028), government officials remain alert over the virus's possible resurgence during the winter.On Monday, Korea reported 22,327 new Covid-19 infections, including 53 cases from overseas, bringing the t
About 30 percent of cancer-related content on social media, including YouTube, is misinformation not verified medically, a recent study showed.A research team, led by Professor Kwon Jeong-hye of the Hemato-oncology Department at Chungnam National University Sejong Hospital, said Monday that it publi
Celltrion said Monday it proved the effectiveness and safety of RemsimaSC (pipeline name: CT-P13 SC), an autoimmune disease treatment, in two global phase 3 trials. RemsimaSC is a subcutaneous injection (SC) form of infliximab, widely used in TNF-α inhibitor market. It is the world’s first inflixima
GC Pharma said on Monday that its neutropenia treatment, Neulapeg (ingredient: pegteograstim), confirmed effectiveness in a phase 2 study on patients with recurrent and refractory multiple myeloma.Neulapeg is a second-generation neutropenia treatment, which is an anticancer adjuvant that prevents he
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent -- The Radiological Society of North America (RSNA) 2022 opened the world's largest radiological conference in Chicago, Ill, the U.S., on Sunday.Compared to last year, the convention was packed with participants and exhibitors as most Co
As poly ADP-ribose polymerase (PARP) inhibitors have recently seen their indications revoked or revised in the U.S., there is also a sign of changing approval details in Zejula (niraparib) in Korea, drawing the industry’s attention.According to anonymous sources on Monday, Takeda Korea is now consid
CGRP (calcitonin gene-related peptide) inhibitors, developed to prevent adult migraines, have recently been registered on the list of insurance beneficiaries, but their reimbursement standards are unrealistic, experts said.“The reimbursement criteria for CGRP inhibitors have been set by Western stan
Inventage Lab, a microfluidic drug delivery platform developer, said on Monday that its IVL4002, a recurrence-relieving multiple sclerosis treatment candidate, is scheduled to receive orphan drug designation (ODD) from the Ministry of Food and Drug Safety (MFDS).IVL4002, an investigational relapsing
Hanmi Pharmaceutical's U.S. partner, Spectrum, said that they would “deprioritize” poziotinib, its lung cancer treatment candidate, after receiving a CRL (Complete Response Letter) from the U.S. FDA at 6 a.m. (KST: 9 p.m.) on Friday.Poziotinib aims to treat non-small cell lung cancer (NSCLC) with lo
The government said on Friday that it will prepare a medical response plan to accommodate an outbreak of Covid-19 confirmed patients of around 200,000 a day expected in winter.Government and quarantine officials estimate that due to the inflow of new mutations and low level of additional vaccination
Daewoong Pharmaceutical held a symposium on Fexuclue, titled “The new wave of GERD (gastroesophageal reflux disease) Treatment,” on Thursday at its headquarters in Samseong-dong, southern Seoul.Thirty-eight “key opinion leaders” from overseas, including the leadership of the Philippine gastrointesti